In a blow to Bharat Biotech who produced Covaxin drug against corona the World Health Organisation (WHO) confirms suspension of the product sold through UN procurement agencies.
This decision by WHO is in response to the outcomes of its post Emergency Use Authorisation (EUL) inspection that was held between 14th and 22nd March, 2022. According to WHO there is requirement for facility upgrade to address recently identified GMP (good manufacturing practice) deficiencies but still Covaxin is stated to be effective and no safety tension exist.
NEIC: SUMI BORA
No comments:
Post a Comment
Your highlight can be precious enough to make a change in the present system for better progress of the nation and so make a step to comment.